Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer

Title
Pretreatment Hematocrit Is Superior to Hemoglobin as a Prognostic Factor for Triple Negative Breast Cancer
Authors
Keywords
Breast cancer, Anemia, Prognosis, Cancer treatment, Hematocrit, Multivariate analysis, Surgical and invasive medical procedures, Hemoglobin
Journal
PLoS One
Volume 11, Issue 11, Pages e0165133
Publisher
Public Library of Science (PLoS)
Online
2016-11-17
DOI
10.1371/journal.pone.0165133

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Add your recorded webinar

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now